Grants per year
- 1 - 25 out of 62 results
Search results
-
Active
Cure SMA Care Center Network and Clinical Data Registry
Families of Spinal Muscular Atrophy
6/1/22 → 5/31/23
Project: Research project
-
HEALEY ALS Platform Trial Regimen-Specific Appendix (RSA) E to Master Protocol TREHALOSE S-005
Massachusetts General Hospital, NexMed, Inc.
3/1/22 → 12/4/24
Project: Research project
-
Protocol Number: A35-004 - Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of AMX0035 Versus Placebo for 48-week Treatment of Adult Patients with Amyotrophic Lateral Sclerosis (ALS)
Julius Clinical Research B.V, Amylyx Pharmaceuticals, Inc.
1/12/22 → 1/12/25
Project: Research project
-
-
I AM ALS: Expanded Access Protocol (EAP) Program Proposal
Massachusetts General Hospital, I AM ALS
9/3/21 → 12/31/22
Project: Research project
-
Prot #BASICHR0053: Evaluation of digital technologies for home-based assessment of ALS patients
Novartis Pharmaceuticals Corporation
8/3/21 → 11/30/22
Project: Research project
-
Prot# MT-1186-A02: A Phase 3b, Multicenter, Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Oral Edaravone Administered for a Period of 48 Weeks in Subjects with Amyotrophic Lateral Sclerosis (ALS)
ICON Clinical Research, LLC, Mitsubishi Tanabe Pharma America, Inc.
3/16/21 → 3/16/24
Project: Research project
-
Prot# 233AS102: An Extension Study to Assess the Long-Term Safety, Tolerability, Pharmacokinetics, and Effect on Disease Progression of BIIB067 Administered to Previously Treated Adults with Amyotrophic Lateral Sclerosis Caused by Superoxide Dismutase 1 M
Quintiles, Inc., Biogen MA Inc.
11/24/20 → 11/24/23
Project: Research project
-
HEALEY ALS Platform Trial Regimen-Specific Appendix (RSA) D to Master Protocol Pridopidine | Double-Blind Phase
Massachusetts General Hospital
11/20/20 → 11/19/22
Project: Research project
-
Prot #233AS101: A Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB067 Administered to Adult Subjects with Amyotrophic Lateral Sclerosis and Confirmed Superoxide Dismutase 1 Mutation
Quintiles, Inc., Biogen MA Inc.
9/9/20 → 9/9/23
Project: Research project
-
Oxidative Markers and Efficacy in ALS/MND Phenotypes Treated with Edaravone: Proof of Concept
Loma Linda University, Mitsubishi Tanabe Pharma America, Inc.
9/2/20 → 9/2/23
Project: Research project
-
Radicava®/(Edaravone) Findings in Biomarkers From ALS (REFINE-ALS)
Massachusetts General Hospital, Mitsubishi Tanabe Pharma America, Inc.
8/3/20 → 8/3/23
Project: Research project
-
PLS Natural History Study
Columbia University, Spastic Paraplegia Foundation, Inc.
7/15/20 → 7/14/22
Project: Research project
-
Prot #ALN-TTR02-012: A Phase 4 Multicenter Observational Study to Evaluate the Effectiveness of Patisiran in Patients with Polyneuropathy of Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with a V122I or T60A Mutation
Quintiles, Inc., Alnylam Pharmaceuticals, Inc.
6/29/20 → 6/29/23
Project: Research project